Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.
- DOI
- 10.1016/j.ejca.2026.117009
- Published
- 2026-08-25
- Container
- Eur J Cancer
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2026.117009,
title = {Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.},
author = {Hersey S and Celik H and Rosen S and Scott C and Keeling P and Joglekar L and Lawler M.},
year = {2026},
journal = {Eur J Cancer},
doi = {10.1016/j.ejca.2026.117009},
url = {https://doi.org/10.1016/j.ejca.2026.117009}
}RIS
TY - JOUR TI - Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe. AU - Hersey S AU - Celik H AU - Rosen S AU - Scott C AU - Keeling P AU - Joglekar L AU - Lawler M. PY - 2026 JO - Eur J Cancer DO - 10.1016/j.ejca.2026.117009 UR - https://doi.org/10.1016/j.ejca.2026.117009 ER -
APA
S, H., H, C., S, R., C, S., P, K., L, J., & M., L. (2026). Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.. Eur J Cancer. https://doi.org/10.1016/j.ejca.2026.117009
Source records
- europe-pmc · retrieved 2026-09-25T05:53:20.330Z